Skip to content

Straumann BLX Implant System SLActive Roxolid BL (REF 061.5308)Recalls & reported problems

Institut Straumann AG · BLX Implant, Ø 4.0mm RB, SLActive® 8mm, Roxolid® · Class 2 · Implant

Quick summary

This Straumann BLX dental implant is a root-form implant placed in the jawbone. Its 3,222 reports mostly describe the implant failing to fuse with the jawbone, with patients reporting scar tissue, pain and swelling. The reports include no deaths and 3,222 injuries. No recalls name this device.

AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.

Adverse event reports
3,244
Deaths reported
0
Injuries reported
3,244
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3,244 adverse event reports that list this exact device (DI 07630031743510), received between Jul 24, 2019 and Sep 28, 2026 — classified as 3,244 injuries.

The most frequently reported specific device problem is “Failure to Osseointegrate” (2,395 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 48 reportsDec 2023: 48 reportsJan 2024: 37 reportsFeb 2024: 49 reportsMar 2024: 43 reportsApr 2024: 60 reportsMay 2024: 42 reportsJun 2024: 46 reportsJul 2024: 46 reportsAug 2024: 57 reportsSep 2024: 69 reportsOct 2024: 91 reportsNov 2024: 84 reportsDec 2024: 43 reportsJan 2025: 55 reportsFeb 2025: 42 reportsMar 2025: 66 reportsApr 2025: 22 reportsMay 2025: 0 reportsJun 2025: 173 reportsJul 2025: 60 reportsAug 2025: 69 reportsSep 2025: 46 reportsOct 2025: 67 reportsNov 2025: 56 reportsDec 2025: 95 reportsJan 2026: 62 reportsFeb 2026: 52 reportsMar 2026: 84 reportsApr 2026: 91 reportsMay 2026: 85 reportsJun 2026: 68 reportsJul 2026: 82 reportsAug 2026: 56 reportsSep 2026: 50 reportsOct 2026: 0 reports202420252026173
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Failure to Osseointegrate2,395
  • Loss of Osseointegration574
  • Adverse Event Without Identified Device or Use Problem244
  • Difficult to Insert26
  • Fracture10
  • Separation Failure5

Patient problems

  • No Clinical Signs, Symptoms or Conditions1,517
  • Fibrosis1,200
  • Pain653
  • Unspecified Infection414
  • Inflammation202
  • Swelling/ Edema141
  • Hemorrhage/Blood Loss/Bleeding114
  • Tissue Damage64

Recent adverse event reports

The 25 most recent of 3,244 reports, in the reporter's own words as published by the FDA.

  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50921906 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50921441 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: Fibrosis

    MAUDE report 50920708 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50920324 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50920316 ↗
  • InjurySep 28, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50920053 ↗
  • InjurySep 18, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50826264 ↗
  • InjurySep 18, 2026Failure to Osseointegrate

    Patient problems: Fibrosis; Hemorrhage/Blood Loss/Bleeding

    MAUDE report 50824961 ↗
  • InjurySep 18, 2026Failure to Osseointegrate

    Patient problems: Fibrosis; Hemorrhage/Blood Loss/Bleeding

    MAUDE report 50823968 ↗
  • InjurySep 17, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6)2026 in FDI 26. On (b)(6)2026, non-osseointegration was verified. The device was forwarded to the manufacturer. There were no reported patient injuries or complications.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50807794 ↗
  • InjurySep 15, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (B)(6) 2026 in FDI 45. On (B)(6) 2026, non-osseointegration was verified. Patient presented with bone type III. No product was returned to the manufacturer. At the event the patient experienced: Pain. No further patient complications were reported.

    Patient problems: Pain

    MAUDE report 50777368 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50760987 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: Swelling/ Edema

    MAUDE report 50760974 ↗
  • InjurySep 14, 2026Loss of Osseointegration

    Patient problems: Fibrosis

    MAUDE report 50760854 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50760811 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: Fibrosis

    MAUDE report 50760508 ↗
  • InjurySep 14, 2026Loss of Osseointegration

    The clinician reports the implant was inserted (b)(6) 2022 in FDI 27. On (b)(6) 2026, loss of osseointegration was verified. The device was forwarded to the manufacturer. There were no patient operative or post-operative complications reported.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50760079 ↗
  • InjurySep 14, 2026Loss of Osseointegration

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50759814 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: Abscess; Hemorrhage/Blood Loss/Bleeding; Inflammation; Unspecified Infection

    MAUDE report 50759713 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: Fibrosis; Pain

    MAUDE report 50759616 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50759446 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    The clinician reports the implant was inserted (b)(6) 2026 in ADA 13. Details of surgery: Primary stability not achieved, Implant surface not completely covered with bone and Immediate extraction site. On (b)(6) 2026, non-osseointegration was verified. Patient presented with bone type III. The device was forwarded to the manufacturer. At the event the patient experienced: Mobility. No further patient complications were reported.

    Patient problems: Fibrosis

    MAUDE report 50757870 ↗
  • InjurySep 14, 2026Failure to Osseointegrate

    Patient problems: Abscess; Hemorrhage/Blood Loss/Bleeding; Inflammation; Unspecified Infection

    MAUDE report 50757704 ↗
  • InjurySep 11, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50738564 ↗
  • InjurySep 11, 2026Failure to Osseointegrate

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50738559 ↗

Other IMPLANT, ENDOSSEOUS, ROOT-FORM devices

All IMPLANT, ENDOSSEOUS, ROOT-FORM devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.